The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort.
Pubmed ID: 19342411
Journal: American journal of respiratory and critical care medicine
Publication Date: July 1, 2009
MeSH Terms: Humans, Male, Adult, Female, Aged, Aged, 80 and over, Aging, Adolescent, Middle Aged, Smoking, Young Adult, Forced Expiratory Volume, Lung, Prospective Studies, Health Surveys, Spirometry, Smoking Cessation
Authors: Mannino DM, Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Soriano JB
Cite As: Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009 Jul 1;180(1):3-10. Epub 2009 Apr 2.
Studies:
- Framingham Heart Study (FHS) Offspring (OS) and OMNI 1 Cohorts
- Systolic Blood Pressure Intervention Trial (SPRINT)
- Systolic Blood Pressure Intervention Trial Primary Outcome Paper (SPRINT-POP) Data
Abstract
RATIONALE: Understanding normal lung development and aging in health and disease, both in men and in women, is essential to interpreting any therapeutic intervention. OBJECTIVES: We aimed to describe lung function changes in healthy never-smoking males and females, from adolescence to old age, and to determine the effects of smoking and those derived from quitting. METHODS: Prospective cohort study within all participants of the Framingham Offspring cohort who had two or more valid spirometry measurements during follow-up (n = 4,391; age range at baseline 13 to 71 yr), with a median follow-up time of 23 years. MEASUREMENTS AND MAIN RESULTS: To best fit the curves describing FEV(1) changes with age to raw data, we used a generalized additive model with smooth terms and incorporating the subject-specific (longitudinal) random effects. We found that: (1) healthy never-smoker females achieve full lung growth earlier than males, and their rate of decline with age was slightly, but not significantly, lower; (2) smoking increases the rate of lung function decline, both in males and in females; (3) there is a range of susceptibility to the effects of smoking. The presence of respiratory symptoms at baseline and/or a respiratory diagnosis during follow-up appears to identify a group of susceptible smokers; and (4) quitting smoking has a beneficial effect at any age, but it is more pronounced in earlier quitters. CONCLUSIONS: Lung function changes from adolescence to old age differ in males and females, smoking has similar deleterious effects in both sexes, and quitting earlier is better.